Antibody response to 1.0 and 0.5 mL doses of an inactivated bacterial vaccine against bovine respiratory disease in young Holstein calves: a field trial
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Allen J.W., Viel L., Bateman K.G., Rosendal S., Shewen P.E., Physick-Sheard P.: The microbial flora of the respiratory tract in feedlot calves: associations between nasopharyngeal and bronchoalveolar lavage cultures. Can J Vet Res 1991, 55, 341–346.AllenJ.W.VielL.BatemanK.G.RosendalS.ShewenP.E.Physick-SheardP.The microbial flora of the respiratory tract in feedlot calves: associations between nasopharyngeal and bronchoalveolar lavage cultures.Can J Vet Res1991,55,341–346.Search in Google Scholar
Billeskov R., Beikzadeh B., Berzofsky J.A.: The effect of antigen dose on T cell-targeting vaccine outcome. Hum Vaccin Immunother 2019, 15, 407–411, doi: 10.1080/21645515.2018. 1527496.BilleskovR.BeikzadehB.BerzofskyJ.A.The effect of antigen dose on T cell-targeting vaccine outcome.Hum Vaccin Immunother2019,15,407–411, doi:10.1080/21645515.2018.1527496.Open DOISearch in Google Scholar
Halasa N.B., Gerber M.A., Berry A.A., Anderson E.L., Winokur P., Keyserling H., Eckard A.R., Hill H., Wolff M.C., McNeal M.M., Edwards K.M., Bernstein D.I.: Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. J Pediatric Infect Dis Soc 2015, 4, 214–224, doi: 10.1093/jpids/piu061.HalasaN.B.GerberM.A.BerryA.A.AndersonE.L.WinokurP.KeyserlingH.EckardA.R.HillH.WolffM.C.McNealM.M.EdwardsK.M.BernsteinD.I.Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.J Pediatric Infect Dis Soc2015,4,214–224, doi:10.1093/jpids/piu061.Open DOISearch in Google Scholar
Hopkins R.J., Kalsi G., Montalvo-Lugo V.M., Sharma M., Wu Y., Muse D.D., Sheldon E.A., Hampel F.C., Lemiale L.: Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults. Vaccine 2016, 34, 2096– 2105, doi: 10.1016/j.vaccine.2016.03.006.HopkinsR.J.KalsiG.Montalvo-LugoV.M.SharmaM.WuY.MuseD.D.SheldonE.A.HampelF.C.LemialeL.Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.Vaccine2016,34,2096–2105, doi:10.1016/j.vaccine.2016.03.006.Open DOISearch in Google Scholar
Mori K., Kato T., Yokota O., Ohtsuka H.: Field trial of primary and booster dose of inactivated vaccine against bovine respiratory bacteria in young Holstein calves. J Vet Res 2020, 64, 223–230, doi: 10.2478/jvetres-2020-0042.MoriK.KatoT.YokotaO.OhtsukaH.Field trial of primary and booster dose of inactivated vaccine against bovine respiratory bacteria in young Holstein calves.J Vet Res2020,64,223–230, doi:10.2478/jvetres-2020-0042.Open DOISearch in Google Scholar
Mori K., Otomaru K., Kato T., Yokota O., Ohtsuka H.: Field trial of antibody response to inactivated bacterial vaccine in young Holstein calves: influence of animal health status. J Vet Res 2022, 66, 109–116, doi: 10.2478/jvetres-2022-0003.MoriK.OtomaruK.KatoT.YokotaO.OhtsukaH.Field trial of antibody response to inactivated bacterial vaccine in young Holstein calves: influence of animal health status.J Vet Res2022,66,109–116, doi:10.2478/jvetres-2022-0003.Open DOISearch in Google Scholar
Nagai K., Otomaru K., Ogawa R., Oishi S., Wataya K., Honkawa Y., Iwamoto Y., Ando T., Hyakutake K., Shirahama H., Habiby G., Kubota C.: Effect of combined vaccination for Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni to prevent respiratory diseases in young Japanese Black calves in the field. J Vet Med Sci 2019, 81, 1355–1358, doi: 10.1292/jvms.19-0256.NagaiK.OtomaruK.OgawaR.OishiS.WatayaK.HonkawaY.IwamotoY.AndoT.HyakutakeK.ShirahamaH.HabibyG.KubotaC.Effect of combined vaccination for Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni to prevent respiratory diseases in young Japanese Black calves in the field.J Vet Med Sci2019,81,1355–1358, doi:10.1292/jvms.19-0256.Open DOISearch in Google Scholar
Otomaru K., Kubota S., Ohtsuka H., Ando T., Koiwa M.: Field application of mixed vaccine including inactivated Pasteurella multocida, Mannhemia haemolytica and Histophilus somni to Japanese Black calves for preventing development of respiratory disease (in Japanese). J Japan Vet Med Assoc 2012, 65, 767– 770, doi: 10.12935/jvma.65.767.OtomaruK.KubotaS.OhtsukaH.AndoT.KoiwaM.Field application of mixed vaccine including inactivated Pasteurella multocida, Mannhemia haemolytica and Histophilus somni to Japanese Black calves for preventing development of respiratory disease (in Japanese).J Japan Vet Med Assoc2012,65,767–770, doi:10.12935/jvma.65.767.Open DOISearch in Google Scholar
Otomaru K., Oishi S., Fujimura Y., Nagai K., Waki H.: Effect of Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni inactivated bacterial vaccine for respiratory disease in young Japanese Black calves in the field (in Japanese). J Japan Vet Med Assoc 2021, 74, 127–131, doi: 10.12935/jvma.74.127.OtomaruK.OishiS.FujimuraY.NagaiK.WakiH.Effect of Pasteurella multocida, Mannheimia haemolytica, and Histophilus somni inactivated bacterial vaccine for respiratory disease in young Japanese Black calves in the field (in Japanese).J Japan Vet Med Assoc2021,74,127–131, doi:10.12935/jvma.74.127.Open DOISearch in Google Scholar
Qadri F., Ahmed T., Ahmed F., Begum Y.A., Sack D.A., Svennerholm A.-M., PTE Study Group.: Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groups. Vaccine 2006, 24, 1726–1733, doi: 10.1016/j.vaccine.2005. 08.110.QadriF.AhmedT.AhmedF.BegumY.A.SackD.A.SvennerholmA.-M.PTE Study Group.: Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6–17 months of age: Dosing studies in different age groups.Vaccine2006,24,1726–1733, doi:10.1016/j.vaccine.2005. 08.110.Open DOISearch in Google Scholar
Scott J.A.G., Ojal J., Ashton L., Muhoro A., Burbidge P., Goldblatt D.: Pneumococcal Conjugate Vaccine Given Shortly After Birth Stimulates Effective Antibody Concentrations and Primes Immunological Memory for Sustained Infant Protection. Clin Infect Dis 2011, 53, 663–670, doi: 10.1093/cid/cir444.ScottJ.A.G.OjalJ.AshtonL.MuhoroA.BurbidgeP.GoldblattD.Pneumococcal Conjugate Vaccine Given Shortly After Birth Stimulates Effective Antibody Concentrations and Primes Immunological Memory for Sustained Infant Protection.Clin Infect Dis2011,53,663–670, doi:10.1093/cid/cir444.Open DOISearch in Google Scholar
Sieng S., Walkden-Brown S.W., Kerr J.: Effect of vaccine storage temperatures and dose rate on antibody responses to foot and mouth disease vaccination in Cambodia. Vet Med Sci 2017, 4, 35–44, doi: 10.1002/vms3.86.SiengS.Walkden-BrownS.W.KerrJ.Effect of vaccine storage temperatures and dose rate on antibody responses to foot and mouth disease vaccination in Cambodia.Vet Med Sci2017,4,35–44, doi:10.1002/vms3.86.Open DOISearch in Google Scholar
Teulieres L., Diouf M.A., Chaud P., Saint-Cyr A., Saliou P.: Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French Guyana. Vaccine 1991, 9, 521–524, doi: 10.1016/0264-410X(91)90040-D.TeulieresL.DioufM.A.ChaudP.Saint-CyrA.SaliouP.Comparative trial of administration of half (0.05 mg) and quarter (0.025 mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year in French Guyana.Vaccine1991,9,521–524, doi:10.1016/0264-410X(91)90040-D.Open DOISearch in Google Scholar
Tucci P., Estevez V., Becco L., Cabrera-Cabrera F., Grotiuz G., Reolon E., Marín M.: Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen. Heliyon 2016, 2, e00158, doi: 10.1016/j.heliyon.2016.e00158.TucciP.EstevezV.BeccoL.Cabrera-CabreraF.GrotiuzG.ReolonE.MarínM.Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen.Heliyon2016,2,e00158, doi:10.1016/j.heliyon.2016.e00158.Open DOISearch in Google Scholar
United States Department of Agriculture: Dairy 2014 – Health and Management Practices on U.S. Dairy Operations, 2014. USDA–APHIS–VS–CEAH–NAHMS, Fort Collins, CO, 2014, https://www.aphis.usda.gov/animal_health/nahms/dairy/downloa ds/dairy14/Dairy14_dr_PartIII.pdf.United States Department of Agriculture: Dairy 2014 – Health and Management Practices on U.S. Dairy Operations, 2014USDA–APHIS–VS–CEAH–NAHMS, Fort Collins, CO,2014,https://www.aphis.usda.gov/animal_health/nahms/dairy/downloa ds/dairy14/Dairy14_dr_PartIII.pdf.Search in Google Scholar
Voysey M., Clemens S.A.C., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., Angus B., Baillie V.L., Barnabas S.L., Bhorat Q.E., Bibi S., Briner C., Cicconi P., Collins A.M., Colin-Jones R., Cutland C.L., Darton T.C., Dheda K., Duncan C.J.A., Emary K.R.W., Ewer K.J., Fairlie L., Faust S.N., Feng S., Ferreira D.M., Finn A., Goodman A.L., Green C.M., Green C.A., Heath P.T., Hill C., Hill H., Hirsch I., Hodgson S.H.C., Izu A., Jackson S., Jenkin D., Joe C.C.D., Kerridge S., Koen A., Kwatra G., Lazarus R., Lawrie A.M., Lelliott A., Libri V., Lillie P.J., Mallory R., Mendes A.V.A., Milan E.P., Minassian A.M., McGregor A., Morrison H., Mujadidi Y.F., Nana A., O’Reilly P.J., Padayachee S.D., Pittella A., Plested E., Pollock K.M., Ramasamy M.N., Rhead S., Schwarzbold A.V., Singh N., Smith A., Song R., Snape M.D., Sprinz E., Sutherland R.K., Tarrant R., Thomson E.C., Török M.E., Toshner M., Turner D.P.J., Vekemans J., Villafana T.L., Watson M.E.E., Williams C.J., Douglas A.D., Hill A.V.S., Lambe T., Gilbert S.C., Pollard A.J., Oxford COVID Vaccine Trial Group: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021, 397, 99–111, doi: 10.1016/S0140-6736(20)32661-1.VoyseyM.ClemensS.A.C.MadhiS.A.WeckxL.Y.FolegattiP.M.AleyP.K.AngusB.BaillieV.L.BarnabasS.L.BhoratQ.E.BibiS.BrinerC.CicconiP.CollinsA.M.Colin-JonesR.CutlandC.L.DartonT.C.DhedaK.DuncanC.J.A.EmaryK.R.W.EwerK.J.FairlieL.FaustS.N.FengS.FerreiraD.M.FinnA.GoodmanA.L.GreenC.M.GreenC.A.HeathP.T.HillC.HillH.HirschI.HodgsonS.H.C.IzuA.JacksonS.JenkinD.JoeC.C.D.KerridgeS.KoenA.KwatraG.LazarusR.LawrieA.M.LelliottA.LibriV.LillieP.J.MalloryR.MendesA.V.A.MilanE.P.MinassianA.M.McGregorA.MorrisonH.MujadidiY.F.NanaA.O’ReillyP.J.PadayacheeS.D.PittellaA.PlestedE.PollockK.M.RamasamyM.N.RheadS.SchwarzboldA.V.SinghN.SmithA.SongR.SnapeM.D.SprinzE.SutherlandR.K.TarrantR.ThomsonE.C.TörökM.E.ToshnerM.TurnerD.P.J.VekemansJ.VillafanaT.L.WatsonM.E.E.WilliamsC.J.DouglasA.D.HillA.V.S.LambeT.GilbertS.C.PollardA.J.Oxford COVID Vaccine Trial Group: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet2021,397,99–111, doi:10.1016/S0140-6736(20)32661-1.Open DOISearch in Google Scholar
Weir C.B., Jan A.: BMI classification percentile and cut off points. In: StatPearls, StatPearls Publishing, Treasure Island 2021, https://www.ncbi.nlm.nih.gov/books/NBK541070.WeirC.B.JanA.BMI classification percentile and cut off points. In:StatPearls, StatPearls Publishing, Treasure Island2021,https://www.ncbi.nlm.nih.gov/books/NBK541070.Search in Google Scholar